Skip to main content
. 2024 Mar 23;57:11. doi: 10.1186/s40659-024-00488-z

Table 2.

Kinetics of development at 48 and 96 h post-insemination (hpi) and cumulative blastocyst rates on Days 7 and 8 after IVC with or without miR-148b mimic or control mimics

IVC
N
Total cleaved
N (%±SEM)
< 16 cells
N
(%±SEM)
≥ 16 cells
N
(%±SEM)
IVC
96 hpi
Blastocysts
D7 D8
N
(%±SEM)
N
(%±SEM)
Control 1001 874 (87.3 ± 0.7) 230 (23.2 ± 0.6) 644 (64.1 ± 0.7) 881 212 (24.4 ± 0.5) 274 (31.2 ± 0.6)
CMimic 1011 878 (86.9 ± 0.6) 229 (22.7 ± 0.4) 649 (64.2 ± 0.7) 891 212 (23.8 ± 0.5) 272 (30.6 ± 0.8)
miR148b 1019 891 (87.5 ± 0.4) 228 (22.5 ± 0.5) 663 (64.9 ± 0.6) 899 217 (24.2 ± 0.6) 282 (31.4 ± 0.8)
miR148b-OV 1052 917 (87.7 ± 0.5) 253 (23.1 ± 0.4) 664 (64.5 ± 0.5) 932 223 (24.4 ± 0.5) 290 (31.0 ± 0.5)
miR148b-UT 1056 927 (87.4 ± 0.5) 245 (23.3 ± 0.6) 682 (63.1 ± 0.4) 936 228 (23.9 ± 0.6) 291 (31.1 ± 0.8)

Embryos cultured from presumptive zygotes to blastocyst in SOF + 0.3% BSA (Control), SOF + 0.3% BSA supplemented with 1 µM control mimics (CMimic), or SOF + 0.3% BSA supplemented with 1 µM of miR-148b (miR148b) or embryos cultured from presumptive zygotes to 16- cell stage in SOF + 0.3% BSA supplemented with 1 µM of miR-148b (miR148b-OV), or embryos cultured from 16-cell stage to BD7 in SOF + 0.3% BSA supplemented with 1 µM of miR-148b (miR148b-UT). Data are the mean ± s.e.m. Within columns, different superscript letters indicate significant difference (P ≤ 0.001) between treatments